万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/scie期刊 >>医药卫生>>传染免疫学

Diabetic Medicine(研究方向:内分泌学与代谢) (官网投稿)

简介
  • 期刊简称待设置
  • 参考译名待设置
  • 核心类别 外文期刊,
  • IF影响因子待设置
  • 自引率待设置
  • 主要研究方向待设置

主要研究方向:

等待设置主要研究方向
待设置

Diabetic Medicine(月刊),创刊于1984年,出版国家为英国。该刊物发表了一系列关于糖尿病各方面的重要信息,常见问题包括研究文章,评论,报告,社论,评论,新闻和通讯。所有材料均经过同行评审。该杂志旨在为全球临床医生和研究人员以及负责照顾糖尿病患者的所有卫生专业人员提供交流信息的论坛。
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊官网:

http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1464-5491

3、期刊投稿:

https://mc.manuscriptcentral.com/dme

4、信息说明:本刊信息来源于网络,包括 SCI 收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友投稿提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

2017426日星期三

                       

 

Author Guidelines

 

1. ABOUT DIABETIC MEDICINE

 

Aims & Scope

 

Diabetic Medicine, the official journal of Diabetes UK, is published monthly in simultaneous print and online editions.

 

As a clinical journal, it publishes a range of key information on all aspects of clinical diabetes mellitus and issues regularly include original articles, reviews, reports, editorials, comment, news and correspondence. All material is peer-reviewed. The journal seeks to provide a forum for the exchange of information between clinicians and researchers worldwide and all health professionals responsible for the care of people with diabetes. Diabetic Medicine does not publish animal or basic science research unless this has direct clinical relevance.

 

Surplus generated from the sale of Diabetic Medicine is used by Diabetes UK to care for, connect with and campaign on behalf of all people affected by and at risk of diabetes.

 

2. MANUSCRIPT CATEGORIES

 

Diabetic Medicine invites the following types of submission:

 

Research articles

 

Original research articles relevant to diabetes mellitus science and practice are the journal’s primary mode of communication. Clinical science and clinically-relevant basic science papers will be considered. Original articles must include a structured abstract (maximum 250 words), should not exceed 3,000 words of text and should be limited to 30 references (Vancouver style, see section 4). Inclusion of supplementary materials in the form of underlying datasets, multimedia files or accompanying slidesets is encouraged.

 

Qualitative research papers may consist of up to 4000 words and 30 references. Anything additional to that should be submitted as supporting information for online publication only.

 

Manuscripts should adhere to reporting standards. Randomised controlled trials should adhere to the CONSORT Checklist. Observational studies should adhere to the relevant STROBE Checklist. Systematic reviews and meta-analyses should adhere to the PRISMA Checklist. Checklists must be completed and submitted electronically with the manuscript using file designation ‘Supporting Document NOT for Publication’.

 

For purposes of presentation only, accepted research articles are divided into the following sections:

 

Care Delivery

Complications

Educational and Psychological Aspects

Epidemiology

Genetics

Health Economics

Metabolism

Pathophysiology

Treatment

 

Reviews

 

The journal aims to publish concise, high-quality review articles of recent advances in laboratory or clinical research. Review articles are usually solicited by the Editor-in-Chief but unsolicited reviews are welcome. All will undergo peer-review. Review articles must include an unstructured abstract (maximum 250 words), should not exceed 5,000 words of text and should be limited to 50 references (Vancouver style, see section 4). Use of illustrations and figures is encouraged.

 

Trial protocols

 

Diabetic Medicine now welcomes submission of trial protocols. Manuscripts must include a structured abstract (maximum 250 words), should not exceed 3,000 words of text and should be limited to 30 references (Vancouver style, see section 4). Inclusion of supplementary materials in the form of underlying datasets, multimedia files or accompanying slidesets is encouraged. For trial protocols of health care interventions, the last section of the abstract should be Trial Registration: listing the trial registry and the unique identifying number, e.g. Trial Registration: Current Controlled Trials ISRCTN73824458. Please note there should be no space between the letters and numbers of the trial registration number. The trial registers that currently meet all of the ICMJE guidelines can be found at http://www.icmje.org/faq_clinical.html . Publishing your trial protocol in Diabetic Medicine does not commit you to submitting subsequent reports of the study to us, although we do, of course, welcome such submissions.

 

Short reports

 

Concise reports of original or important observations, short reports should not exceed 1,500 words and are limited to one figure, one table and 20 references (Vancouver style, see section 4). A structured abstract is required.

 

Case reports

 

Case reports submitted after 1 May 2012 will be published online-only in Diabetic Medicine. The abstracts of case reports will continue to be published in the relevant print issue. Case reports remain fully citable and will continue to be indexed by PubMed.

 

Case reports should describe unusual clinical cases and must carry a new or important message. Cases that present a diagnostic, ethical or management challenge, or that highlight aspects of mechanisms of injury, pharmacology or histopathology are deemed of particular educational value. Descriptions of a series of cases stand a greater chance of being accepted. The Editors reserve the right to ask authors to revise a single case report into a Letter to the Editor.

 

Case reports should not exceed 1,500 words and are limited to 3 tables and/or 3 figures and 20 references. A structured abstract (maximum 250 words) must be provided using the following sub-headings: Background, Case Report, Discussion. The submission of supplementary materials (additional figures, tables, datasets, multimedia files, etc.) which add value to cases is encouraged.

 

Letters

 

Items of correspondence may be in response to issues arising from recently published articles, or short, free-standing pieces expressing an opinion. Letters should be formatted in one continuous section and should not exceed 800 words, 1 figure/table and 10 references. No abstract is required. Please give the name(s) and affiliation(s) of authors at the end of the letter. All letters are subject to peer-review.

 

Editorials/Commentaries

 

Editorials and commentaries provide expert opinion to hot topics. Whilst typically commissioned by the Editors, unsolicited submissions are welcome. Editorials and commentaries should not exceed 1,000 words and 10 references (Vancouver style, see section 4). No abstracts are required.

 

Word Counts:

 

Research Articles:

Quantitative: structured abstract (maximum 250 words), up to 3,000 words of text, 30 references

Qualitative: structured abstract (maximum 250 words), up to 4000 words, 30 references. Anything additional to that should be submitted as supporting information for online publication only.

 

Reviews: unstructured abstract (maximum 250 words), up to 5,000 words of text, 50 references.

Trial protocols: structured abstract (maximum 250 words), up to 3,000 words of text, 30 references

 

Short Reports: structured abstract (maximum 250 words), 1,500 words, one figure, one table, 20 references.

 

Case Reports: structured abstract, 1,500 words, 3 tables and/or 3 figures, 20 references.

 

Letters: no abstract required, 800 words, 1 figure/table, 10 references.

 

3. SUBMISSION OF MANUSCRIPTS

 

All submissions must be made online at the Diabetic Medicine ScholarOne Manuscripts site. New users should first create an account. Once a user is logged onto the site, submissions should be made via the Author Centre.

 

All authors listed within the manuscript as co-authors must be added as co-authors in the Scholar One Manuscripts site. If the author lists on the site and within the manuscript do not match, your submission will be returned to you for changes.

 

A Submission Checklist is available to help authors comply with the journal style and the submission requirements.


投稿问答最小化  关闭